MyFinsight
Home
Blog
About
Net loss
attributable to volitionrx...
-$7,326,047
(-16.58%↓ Y/Y)
Net loss
-$7,315,263
(-15.86%↓ Y/Y)
Net loss
attributable to...
$10,784
(-64.04%↓ Y/Y)
Product
$398,657
(62.78%↑ Y/Y)
Operating loss
-$4,155,983
(34.01%↑ Y/Y)
Total other income
(expenses)
-$3,159,280
(-19326.18%↓ Y/Y)
Total revenues
$398,657
(-1.97%↓ Y/Y)
Gain (loss) on change
in fair value of...
$1,162
(101.85%↑ Y/Y)
Gain on disposal of
fixed assets
$341
(3.33%↑ Y/Y)
Interest income
$163
(1.88%↑ Y/Y)
Total operating
expenses
$4,554,640
(-32.07%↓ Y/Y)
Loss (gain) on change
in fair value of...
-$1,374,076
(-428.19%↓ Y/Y)
Interest expense
$740,388
(500.20%↑ Y/Y)
Loss on
extinguishment of debt
-$595,500
Amortization of debt discount
$405,068
(24.52%↑ Y/Y)
Grant income (loss)
-$45,914
(-160.42%↓ Y/Y)
General and
administrative
$2,205,471
(-25.00%↓ Y/Y)
Research and development
$1,800,656
(-33.80%↓ Y/Y)
Sales and marketing
$548,513
(-47.44%↓ Y/Y)
Back
Back
Income Statement
VOLITIONRX LTD (VNRX)
VOLITIONRX LTD (VNRX)
source: myfinsight.com